The control of normal cellular proliferation is mediated through the action of hormones and growth factors (1-3).
Growth regulation of tumor cells is less well understood, although evidence suggests that tumor cells are capable of responding to growth signals as well as their normal counterparts (4, 5) .
A major storage site for many important biomolecules is the platelet. In addition to containing molecules essential for hemostasis (6) , human platelets also store growth factors for a variety of cell types. PDGF induces the competent state in fibroblasts (7) . TGF-B is a bifunctional growth regulator with
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VoI. 138, No. 2, 1986 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS both inhibitory and stimulatory activities depending on cell type and culture conditions (8) . An epidermal growth factor-like activity has been described in human platelets as well (9) . EGF in combination with PDGF and TGF-B can induce the transformed phenotype in NRK fibroblasts. Another growth factor activity that has been demonstrated in human p!atelets, but is largely uncharacterized, which promotes growth of normal endothelial cells (i0).
We have recently identified a novel melanoma growth factor activity from human platelets (ii). This MGF is acid-sensitive and induces the expression of the transformed phenotype for melanoma cells in serum-free medium as measured by growth in soft agar.
We have previously shown this activity to be distinct from
PDGF, TGF-B, and EGF (i!).
We now describe the biological activity of a partially purified human platelet preparation on human melanoma and bovine aortic endothelial cells.
MATERIALS AND METHODS

Tissue cultures
The human melanoma cell line, MIRWS, was established from a patient tumor biopsy sample that had been successfully cloned in agar, as previously described (12) .
The cells were maintained in monolayer culture in DMEM (GIBCO, Santa Clara, CA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (GIBCO), glutamine (0.8 ug/ml; Irvine scientific, Santa Ana, CA).
The rodent fibroblast cell line, AKR-2B was provided by Dr. Harold Moses, Vanderbilt University, Nashville, TN.
The bovine aortic endothelial cells were provided by Dr. John Castellot, Harvard Medical School, Cambridge, MA.
AKR-2B cells were cultured in 10% FBS, DMEM, and the endothelial cells were cultured in 20% FBS, RMPI (GIBCO).
Gel filtration HPLC of platelet sonicat@
The preparation of neutral platelet sonicate has been described (ii).
The crude sonicate was fractionated on a HPLC gel filtration column (TSK SW3000, Beckman Instruments, Berkeley, CA).
The HPLC system used was Beckman Model System 334. Calcium and magnesium-free PBS, pH 7.5, was used as the eluent at a flow rate of 0.5 ml/hour.
One milliliter fractions were collected. The fractions that were bioloqically active on MIRW5 cells were pooled, dialyzed against distilled water and lyophilized for further study.
Soft agar assays
Growth of human melanoma in soft agar has been described (ii). The fibroblasts and endothelial cells were plated in soft agar in their respective maintenance medium.
MIRW5 cells were plated at 5,000 cells/plate.
The AKR 2-B cells were plated at i0,000 cells/plate.
The endothelial cells were plated at 20,000 cells/plate.
The active fraction from HPLC (1.75 ug/ml) was plated with each cell type in the overlayer.
Monolayer assays
The MIRW5, AKR 2B and endothelial cells were evaluated in monolayer culture for response to the active fractions from HPLC. The cells were seeded at a concentration of 300,000-500,000 cells/ 60 mm dish.
After overnight incubation the assay medium was added with or without fractions from HPLC (43 ug/ml protein). MIRW5 assay medium was 1% BSA, DMEM.
For all monolayer assays, the fibroblasts and endothelial cells were counted in 1% FBS, DMEM or RPMI.
After 24-36 hours incubation at 37°C, the cells were harvested by scraping and counted using a hemocytometer counter.
The effect of fraction 16 on the incorporation of 3H-thymidine (HEN, Boston, MA) into newly synthesized DNA was determined.
1-2 uCi/ml 3H-thymidine was added to the dishes 18-24 hours after treatment with fractions from HPLC (43 ug/ml). Dishes were incubated at 37°C for one hour.
Cells were harvested by scraping and washed three times with PBS with i00 ug/ml BSA. Trichloroacetic acid was added to the cell suspensions to achieve a final concentration of 10% TCA.
The precipitate was collected and counted after overnight incubation at 4°C.
Bindinq Studies
Radiolabeling of fraction 16
Approximately 25 ug of protein from fraction 16 was radioiodinated with 125I-labeled Bolton Hunter reagent (HEN; 13.4 mCi/ml).
Lyophilized protein was dissolved in 50 ul of PBS, pH 8.0 and transferred to the reaction vial containing the reagent. The reaction was allowed to proceed at 4°C for 2 hours with occasional agitation.
The reaction was stopped by the addition of 50 ul of i0 mM TRIS, PBS.
Labeled protein was separated from free iodine by Sephadex G-25 chromatography using PBS as the eluent.
Time course of binding for MIRWS.
Confluent monolayers of MIRW5 cells in 12 well dishes were washed three times with binding buffer (DMEM, 1 mg/ml BSA, 50 mM BES, pH 6.8) to remove FBS. 400,000 cpm (650 ng) of labeled fraction 16 were added to each well in 0.5 ml of binding buffer. The dishes were incubated at room temperature for the times indicated.
To determine nonspecific binding, a 500-fold excess of unlabeled fraction 16 was added per well prior to the addition of labeled protein.
After the specified times, the assay was stopped by aspiration of the binding buffer.
The cells were washed three times with cold buffer, and the cells were solubilized with 0.2 N NaOH for gamma counting.
Protein determination.
Protein concentrations were determined by using Bio-Rad Protein Assay (Bio-Rad Laboratories, Richmond, CA).
This assay is based on the Bradford method utilizing Coomassie Brilliant Blue G-250 to assess protein binding.
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RESULTS
Gel filtration HPLC of platelet sonicate
The fractionation of the crude platelet sonicate over the TSK SW3000 column resulted in 800-fold purification of the human melanoma stimulatory activity. co-purified. The TSK gel filtration fractions were assayed for mitogenicity on endothelial cell monolayer growth and melanoma soft agar growth. Figure 2 demonstrates that fraction 16 gave optimal stimulation of both cell types.
To further assess the specificity of these responses, fibroblasts, melanoma and endothelial cells were evaluated for colony formation in soft agar and 3H-thymidine uptake in monolayer. Table 1 
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